Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 6, 2000, Pages 926-931

  Mancia, Giuseppe ^a   Omboni, Stefano ^b   Agabiti Rosei, Enrico ^d   Casati, Rodolfo ^d   Fogari, Roberto ^d   Leonetti, Gastone ^b   Montemurro, Giuseppe ^d   Nami, Renato ^d   Pessina, Achille C ^d   Pirrelli, Anna ^d   Zanchetti, Alberto ^c  

^a SAN GERARDO HOSPITAL   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NONE

Author keywords

Ambulatory blood pressure monitoring; Diabetes mellitus; Enalapril; Essential hypertension; Manidipine; Office blood pressure

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MANIDIPINE; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE METABOLISM; HEART RATE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIASTOLE; DIHYDROPYRIDINES; DOUBLE-BLIND METHOD; ENALAPRIL; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SYSTOLE; TREATMENT OUTCOME; TRIGLYCERIDES; URIC ACID;

EID: 12944254453     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200006000-00015     Document Type: Article

References (10)

1. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998;317:703-13.
2. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999;353:611-6.
3. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial: HOT Study Group. Lancet 1998;351:1755-62.
4. Tuomilehto J, Rastenyte D, Birkenhager WH, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension: Systolic Hypertension in Europe Trial Investigators. N Engl J Med 1999;340:677-84.
5. Epstein M. Diabetes and hypertension: the bad companions. J Hypertens 1997;15(suppl 2):S55-62.
6. Ferrari P, Rosman J, Weidmann P. Antihypertensive agents, serum lipoprotein and glucose metabolism. Am J Cardiol 1991;67:26B-35B.
7. Stein PP, Black HR. Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 1991;14:425-8.
8. Bressler P, De Fonzo RA. Drugs and diabetes. Diabetes Rev 1994;2:53-84.
9. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependent diabetes and hypertension. N Engl J Med 1998;338:645-52.
10. Tatti P, Pahor M, Byington RP, et al. Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998;21:597-603.